WRLD

Search

#GLP
Rzeczpospolita 1d

Dentists are warning about the side effects of using GLP-1 medications, referred to as "Ozempic teeth," which can lead to oral health problems such as cavities, enamel erosion, and dry mouth. #zdrowie #dentystyka #Ozempic (translated)

www.rp.pl
Dentyści ostrzegają przed „ozempicowymi zębami”. Wymieniają objawy
2191
Eva Herman 1d
German author and former television presenter

The author wrote that he initially assumed the video was fake. According to his account, however, the montage showed genuine footage and photos of thin Hollywood stars. He pointed out that numerous celebrities had publicly admitted to taking GLP-1 medications such as Ozempic, Wegovy, or Mounjaro, including Oprah and Serena. (translated)

2577
LaVanguardia 2d

The FDA has ordered manufacturers of drugs containing GLP-1 receptor agonists to include warnings about the risk of developing anterior ischemic optic neuropathy, a condition that can lead to vision loss, although experts maintain that the benefits of these drugs continue to outweigh the potential risks. #FDA #semaglutida #obesidad (translated)

www.lavanguardia.com
La FDA ordena advertir sobre el riesgo de ceguera por los fármacos adelgazantes
3206
Observador 3d

China has authorized the marketing of the first oral GLP-1 pill for weight loss, aimed at adults with excess weight who have at least one weight-related disease, opening new opportunities in the obesity treatment market. #Obesidade #Saúde #China (translated)

observador.pt
China comercializa primeiro comprimido GLP-1 para emagrecer
3351
Sigma Live 3d

The increasing use of injectable weight-loss medications, such as GLP-1, requires medical guidance due to health risks, dietary pitfalls, and the need for proper nutrition and exercise. #Αδυνάτισμα #Υγεία #Διατροφή (translated)

www.sigmalive.com
Ενέσιμα αδυνατίσματος: Οι κίνδυνοι για την υγεία και οι διατροφικές παγίδες
2907
BFMTV 4d

Eli Lilly becomes the first American lab to obtain approval in China for a weight loss pill based on GLP-1, thus gaining an advantage over its competitor Novo Nordisk in the obesity market. #EliLilly #GLP1 #Obésité (translated)

www.bfmtv.com
Eli Lilly prend l'avantage sur son rival Novo Nordisk: le laboratoire américain décroche la première autorisation en Chine pour un comprimé GLP-1 amaigrissant
3254
eldiario.es 4d

The FDA has required drug manufacturers such as Ozempic to modify their labels to include warnings about a low risk of non-arteritic anterior ischemic optic neuropathy in patients using GLP-1 agonists for diabetes and obesity. #Ozempic #Diabetes #Salud (translated)

www.eldiario.es
La FDA exige cambiar la etiqueta en fármacos como Ozempic para alertar del riesgo de enfermedad ocular rara
3142
Onet.pl 4d

The U.S. Food and Drug Administration (FDA) is issuing a warning on GLP-1 medications, such as Ozempic and Wegovy, due to the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to sudden and permanent vision loss in one eye. #NAION #zdrowie #cukrzyca (translated)

www.onet.pl
"Udar oka" po zastrzykach na odchudzanie. Amerykanie ostrzegają
3030
20 minutos 4d

GLP-1 drugs, initially designed to treat type 2 diabetes and obesity, show promise in reducing the severity of psoriasis, although more research is needed to confirm their efficacy and safety in this context. #Psoriasis #GLP1 #Salud (translated)

www.20minutos.es
¿Podrían los fármacos GLP-1 ayudar a tratar la psoriasis? Esto es lo que dice la ciencia
3034
Bild 5d

A study with over 80,000 patients with type 2 diabetes shows that discontinuing GLP-1 medications significantly increases the risk of heart attacks, strokes, and increased mortality. #Typ2Diabetes #Herzgesundheit #GLP1Medikamente (translated)

www.bild.de
Bei Diabetikern - Abnehmspritzen-Stopp erhöht Herzrisiko
3044
BBC 5d

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION. #GLP1Drugs #EyeHealth #FDAWarnings

www.bbc.co.uk
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
3390
Sigma Live 6d

The FDA issued a warning about GLP-1 medications, such as Ozempic and Wegovy, due to a possible increase in the risk of NAION, a rare ophthalmological condition that can lead to vision loss, although a causal relationship has not been established. #ΔημόσιαΥγεία #Ozempic #NAION (translated)

www.sigmalive.com
Ozempic και Wegovy: Προειδοποίηση του FDA για πιθανό κίνδυνο απώλειας όρασης
3166
IndexHR 6d

The American Food and Drug Administration (FDA) has issued new warnings for GLP-1 class medications, including Ozempic, due to the risk of a rare but serious eye disease that can cause vision loss. #Ozempic #NAION #lijekovizamršavljenje (translated)

www.index.hr
Izdana nova upozorenja za Ozempic i slične lijekove. Razlog je rizik od gubitka vida
3287
Prof. Karl Lauterbach 7d
German politician and former Federal Minister of Health

The author wrote that GLP-1 medications for obesity apparently also improve knee osteoarthritis independently of weight loss by reducing inflammation in the knee. This would make movement and sports possible again. He expressed hope that prices would drop soon. #Gesundheit #Arthrose #Gewichtsreduktion #DE (translated)

2948
20 minutos 1w

Nutritionist María José Crispín warns that the treatment with GLP-1 medications for obesity should focus on a long-term approach and the personalization of the dosage, avoiding the obsession with rapid weight loss. #GLP1 #PérdidaDePeso #Nutrición (translated)

www.20minutos.es
María José Crispín, nutricionista, sobre los GLP-1: "Subir y subir la dosis no puede ser el objetivo”
2970

The discontinuation of GLP-1 medications, such as Ozempic and Mounjaro, may negate the significant cardiovascular benefits they offer, highlighting the risk of heart attack and stroke in individuals who discontinue them. #Ozempic #Mounjaro #Υγεία (translated)

www.tovima.gr
Ozempic – Mounjaro: H αόρατη «ασπίδα» της καρδιάς χάνεται μετά τη διακοπή τους
3206
eldiario.es 2w

Novo Nordisk has launched Wegovy in Spain, the first oral GLP-1 receptor agonist for weight control, which, along with lifestyle changes, can achieve weight loss of 17%, consolidating its importance in the growing market for obesity medications. #Obesidad #Wegovy #Salud (translated)

www.eldiario.es
El mercado de fármacos contra la obesidad sigue creciendo con la pastilla de Wegovy
3325
Dr Dim. Papadimitriadis 3w
Greek psychiatrist and psychotherapist

The author noted that a new study found a link between GLP-1 medications and fewer hospitalizations in individuals with schizophrenia, while experts called for caution in interpreting the findings. https://t.co/w6QOwrItzt #υγεία #παθήσεις #φάρμακα #GR (translated)

3246
BBC 3w

The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us". #WeightLoss #BeautyIndustry #Skincare

www.bbc.co.uk
L'Oreal says weight loss drugs are impacting beauty and skincare sales
2899
D
der Standard 3w

Heineken warns British pubs of a decline in sales due to the increasing use of GLP-1 preparations, which increase feelings of fullness and reduce cravings for alcohol. #Heineken #Pubs #Alkoholkonsum (translated)

www.derstandard.at
Heineken warnt britische Pubs vor Umsatzrückgang durch Abnehmspritzen
2783